Drug Trial Radar · NCT01519752
A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis
Last checked: Nov 20, 2026Latest source record: Jan 22, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
661
Actual
Start
Nov 2011
Primary completion
Aug 2012
Study completion Nov 2012
Sponsor
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 27, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to demonstrate that Oxiconazole nitrate 1% topical cream is effective for the treatment of patients with moderate to severe Tinea pedis.
Conditions
- Tinea Pedis
Interventions
Oxiconazole Nitrate Cream 1%Drug
Oxiconazole Nitrate Cream 1% applied to affected area once a day for 28 days
Oxiconazole Nitrate Cream 1% (Oxistat®)Drug
Oxiconazole Nitrate Cream 1%(Oxistat®)applied to affected area once a day for 28 days
PlaceboDrug
Placebo applied to affected area once a day for 28 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Therapeutic CureTime frame: Day 42
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.